InvestorsHub Logo
Followers 29
Posts 1568
Boards Moderated 0
Alias Born 01/29/2011

Re: None

Wednesday, 04/03/2019 12:52:30 PM

Wednesday, April 03, 2019 12:52:30 PM

Post# of 23619
The patent applications in Canada also cover the Company’s new compound, LACTOACTIVE iTHER®, a LACTOACTIVE® variant that offers potent immune-system enhancement with a potential for treating a wide range of diseases. LACTOACTIVE iTHER® is expected to generate new revenue streams in addition to the company’s LACTOACTIVE®-based therapeutic skincare range.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.